<\/p>\n
Africa\u2019s healthcare sector is attracting unprecedented investor interest, and the Corporate Finance team at Nedbank Corporate and Investment Banking (CIB) is at the centre of this trend.<\/p>\n
The investment bank recently advised Ethos on the competitive disposal of its investment in Vertice MedTech, a transaction that drew international buyer interest and underscores the growing appeal of healthcare assets in emerging markets.<\/p>\n
The transaction forms part of Ethos Fund VI\u2019s ongoing realisation strategy, marking a significant milestone for Ethos and showcasing Nedbank CIB\u2019s advisory capabilities.<\/p>\n
Vertice MedTech is a leading independent distributor of specialised medical devices and mobile healthcare solutions.<\/p>\n
The company plays a critical role in healthcare delivery across South Africa and other African markets, enabling more than 7\u00a0000 surgeries every month and supporting national health programmes through mobile medical units.<\/p>\n
Its portfolio spans advanced medical devices, software service and health IT consulting \u2013 all of which are essential for improving healthcare access and outcomes in a region where demand for modern medical solutions is rising sharply.<\/p>\n
The business also has a growing technological presence in Europe, demonstrating the global nature of modern healthcare companies.<\/p>\n
Acting as corporate advisor to both Ethos and Vertice MedTech, Nedbank CIB guided the transaction through a competitive process that attracted strong interest from international buyers.<\/p>\n
This outcome reinforces the bank\u2019s ability to execute complex private equity exits and cross-border transactions, particularly in sectors that require deep technical knowledge and strategic insight.<\/p>\n
\u201cHealthcare continues to gain momentum as a value-adding investment industry,\u201d says Avinash Kalkapersad, investment banking originator at Nedbank CIB.<\/p>\n
\u201cOur involvement in this transaction underscores our ability to deliver strategic outcomes for clients in sectors that matter.\u201d<\/p>\n
Michael Jensen, a partner at Ethos, explains: \u201cHaving grown Vertice MedTech since its acquisition in 2018, we determined that the timing was right to exit in line with our broader asset realisation strategy.<\/p>\n
\u201cNedbank CIB\u2019s expert advice ensured a successful transaction.\u201d<\/p>\n
Michael Jensen, a partner at Ethos. Image: Supplied<\/p>\n
The deal comes at a time when healthcare investment across Africa is accelerating, driven by demographic shifts, rising demand for specialised services and the need for technology-enabled solutions.<\/p>\n
For investors, the sector offers a compelling combination of financial returns and social impact, making it one of the most attractive areas for capital deployment in emerging markets.<\/p>\n
By facilitating the deal, Nedbank CIB has demonstrated its ability to secure global acquirers for strategic African assets \u2013 a capability that is increasingly important as cross-border dealmaking becomes more competitive.<\/p>\n
The bank has positioned itself to be a key player in the healthcare sector, which continues to grow, driven by ageing populations, technological advancements, a rising prevalence of chronic diseases, and the expansion of the global middle class.<\/p>\n
For Nedbank CIB, this transaction is more than a deal. It is a testament to its ability to combine sector expertise with strategic insight, delivering solutions that create value for clients and communities alike.<\/p>\n
As healthcare investment accelerates across Africa, Nedbank CIB remains at the forefront, shaping the future of advisory excellence in sectors that matter most.<\/p>\n
Healthcare is not just an investment opportunity; it is a sector that directly impacts lives. Transactions such as this enable companies like Vertice MedTech to continue delivering essential services, drive innovation and support health outcomes across Africa.<\/p>\n
For investors and stakeholders, these deals represent the intersection of financial performance and social impact \u2013 a space in which Nedbank CIB is committed to leading.<\/p>\n
Brought to you by Nedbank CIB.<\/p>\n
Moneyweb does not endorse any product or service being advertised in sponsored articles on our platform.<\/p>\n
#Nedbank #CIB #advises #Ethos #Vertice #MedTech #exit #Amethisled #consortium<\/p>\n","protected":false},"excerpt":{"rendered":"
Africa\u2019s healthcare sector is attracting unprecedented investor interest, and the Corporate Finance team at Nedbank…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[10949,10953,4874,10954,10950,234,10952,4121,10951],"_links":{"self":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts\/5517"}],"collection":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5517"}],"version-history":[{"count":0,"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts\/5517\/revisions"}],"wp:attachment":[{"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}